To confirm if TEX41 expression could be associated with B-ALL onset, we tested by q-RT-PCR its expression values in 10 B-ALL patients at the moment of diagnosis and at day + 33 after induction therapy, when the minimal residual disease was undetectable according to the clinical reports (data not shown). Here, TEX41 is linked to acute lymphoblastic leukemia.